Next week, join Ashland for a pharma webinar, "advances in melt granulation technologies to improve product and process performance". The advent of functional excipients optimized for melt granulation can enable the broader adoption of continuous manufacturing (CM) and the ESG benefits to be achieved. Melt granulation has less inherent environmental impact than wet granulation. Because no water is required, water consumption is reduced, and no drying step is required, reducing energy consumption. The elimination of the drying step and the improved performance of new thermal binders have also been shown to reduce overall processing time. We will cover thermal binders that enable melt granulation of immediate-release and controlled-release oral solid dosage pharmaceutical formulations. Sign up now - https://bit.ly/4euD4U2
Ashland’s Post
More Relevant Posts
-
Who helps make paint formulations more sustainable? We do. The coatings team in India successfully hosted two technical seminars in Indore on June 14 and in Pune on June 28 to introduce easy-wet™ substrate wetting agents and nutra shield™ 200 pH neutralizers to more than 100 water-based paint manufacturers. The seminars included hands-on activities and presentations focusing on how to produce sustainable and low- VOC solutions. Learn more - https://bit.ly/3xKpN9p
-
-
Who advances drug delivery? We do. Join Ashland solvers at CRS 2024 Annual Meeting and Exposition, in Bologna, Italy, July 8-12, booth 26. Plan to attend our educational workshop, “Long Acting Injectables: Microsphere and Implant Design, Development and Scale Up Using Chroniject™ with Viatel™ Lactide / Glycolide Polymers” on Monday afternoon, co-presented with Oakwood Labs, MeltPrep, Sever Pharma Solutions, and Queen’s University Belfast. We are also presenting “Risperidone-Loaded Sustained Release Implants – From Benchtop to Commercial Scale” on July 9 at 9:00 a.m. Look for us. https://bit.ly/3xDmFw3
-
-
Who enables release over time? We do. Ashland will be at CRS 2024 annual meeting and expo, in Bologna, Italy, July 8-12, booth 26. On Monday July 8 at 1:00 p.m., our solver Brad Minrovic, PhD will hold an exciting workshop on Ashland innovation platform viatel™ bioresorbable polymers with cooperation partner Oakwood Labs, MeltPrep, Sever Pharma Solutions, and Queen’s University Belfast. Solver Patrick Duffy, PhD will give an insightful talk on Tuesday at 9:00 a.m. about risperidone-loaded sustained release implants. See you there. https://bit.ly/4bmJmlW
-
-
Who is making construction more efficient? We are. Ashland is making cement work better in the tile adhesion segment by offering culminal™ UP 1268 modified MHEC, a new grade of culminal™ with excellent wetting properties and high, early and final adhesion strength for the significant amounts of cement used in applying large tiles. Learn more - https://bit.ly/3RFZuIk
-
-
On June 26 and June 27 Ashland shares an opportunity for you to evaluate advances in melt granulation methods and learn how these advances can be leveraged to improve pharmaceutical manufacturing efficiency, reduce production costs, and reduce environmental impact. Join us as we discuss the implementation of continuous manufacturing in the pharma industry. Register now for our webinar, "advances in melt granulation technologies to improve product and process performance". https://bit.ly/4euD4U2
-
-
Who is energized to continue solving with you? We are. Thank you for joining us at The Battery Show Europe in Stuttgart, Germany. Through the innovation of breakthrough technologies, Ashland is recharging the battery market. Find out more information and explore: https://bit.ly/3zicDAO
-
-
If you're interested in using melt granulation for pharma manufacturing, this webinar will provide solid information. #pharma #innovation
Next week, join Ashland for a pharma webinar, "advances in melt granulation technologies to improve product and process performance". The advent of functional excipients optimized for melt granulation can enable the broader adoption of continuous manufacturing (CM) and the ESG benefits to be achieved. Melt granulation has less inherent environmental impact than wet granulation. Because no water is required, water consumption is reduced, and no drying step is required, reducing energy consumption. The elimination of the drying step and the improved performance of new thermal binders have also been shown to reduce overall processing time. We will cover thermal binders that enable melt granulation of immediate-release and controlled-release oral solid dosage pharmaceutical formulations. Sign up now - https://bit.ly/4euD4U2
-
-
Do you need better adhesion for large tile projects? Ashland Culminal™ Up 1268 modified MHEC is an enhanced-performing additive designed for greater adhesion and effectiveness when using larger tiles that require more cement in construction. This grade is part of the robust Culminal™ methylcellulose derivatives portfolio— developed to help with the easy application and efficiency of building materials for higher performance. Learn More Here - https://bit.ly/3VVNZPy
-
-
Who delivers meaningful, innovative solutions? We do. Join Ashland solvers at The Battery Show Europe, Stuttgart, Germany, June 18–20, 2024. Our application specialists will provide expert technical assistance and offer insight to our products' unique and highly functional performance in complex formulations. Visit us at booth 4-F65 to learn more. https://bit.ly/3RyEDGI
-
